The U.S. Food and Drug Administration has approved Eli Lilly's Omvoh (mirikizumab-mrkz) for the treatment of moderately to ...
FDA approves Eli Lilly's Omvoh for Crohn's disease, showing strong Phase 3 results in clinical remission and intestinal ...
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...
In the pivotal Phase 3 VIVID-1 trial, patients treated with Omvoh experienced significant improvement in clinical remission and endoscopic respons ...
First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in ...
For health conditions with no cure, effective treatments are the next best option. However, in order to make medical ...
Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the "Company" or "Spyre"), a clinical-stage biotechnology company utilizing best-in-class antibody engineering, rational therapeutic combinations, and ...
The Crohn’s and Colitis Foundation’s 34th annual Torch Gala is set to take place on Saturday, Feb. 8 in Atlanta, with three ...
If you have an inflammatory bowel disease like Crohn’s or ulcerative colitis and have trouble focusing or remembering things, ...
With time, many people are diagnosed with ulcerative colitis or Crohn's disease, which helps determine the best treatment and management options. Tontini GE, Vecchi M, Pastorelli L, Neurath MF, ...
GlaxoSmithKline has suffered another research setback after it axed a phase 2 trial of an anti-LAG3 drug in patients with ulcerative colitis, following a major disappointment with a key lung ...
Learn more If you have a cat, it's important to protect their health with one of the best flea treatments for cats. Cats with severe flea infestations can suffer from skin damage, an allergic ...